3,894 followers
New Research: CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective: CDK4/6 inhibitors have become game-changers in the treatment of estrogen receptor-positive (ER+) breast cancer, and in combination with… https://t.co